Shana Tova from Protai !! 🍯🍎 Wishing everyone a happy, healthy, and sweet new year. May this year bring us all growth, resilience, and meaningful breakthroughs in healthcare. #ShanaTova #HappyNewYear
Protai
Biotechnology Research
Empowering drug discovery with Proteomics and ML to unlock complex biological insights and enable better therapeutics.
עלינו
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.
- אתר אינטרנט
-
http://protai.bio
קישור חיצוני עבור Protai
- תעשייה
- Biotechnology Research
- גודל החברה
- 2-10 עובדים
- משרדים ראשיים
- Tel Aviv
- סוג
- בבעלות פרטית
- הקמה
- 2021
מיקומים
-
הראשי
Tel Aviv, IL
עובדים ב- Protai
-
Lior Handelsman
General Partner at Grove Ventures
-
Ittai Harel
Managing Partner, Pitango HealthTech
-
Sharon Shacham
Co-Founder and Managing Partner at E44 Ventures | Founder at Karyopharm Therapeutics Inc | Board Member | Climate Tech | Israeli American Entrepreneur
-
Alexey Nesvizhskii
Godfrey Dorr Stobbe Professor of Bioinformatics, University of Michigan
עדכונים
-
Our CTO Kirill Pevzner, speaking about #AI and #Pharma
Last week I represented Protai in #AI for #Pharma panel discussion. It was great to hear perspectives from colleagues David H. from CytoReason, Dov Gertz form Converge Bio and Shaun Regenbaum from Tissue Dynamics . We can all take pride that our #data driven #biotech companies in #Israel continue to push forward in the journey to positively impact patients health, through diverse business models and technological innovations. Thank you Arik Kol, Yaniv Jember for putting this event together and NVIDIA for hosting this event.
-
Protai CTO Kirill Pevzner is live in #ESMO24
Now live at #ESMO24, Protai is presenting 2 posters: 190P - A large scale proteogenomics atlas for precision oncology research 1957P - Integrative proteomic profiling in high-grade serous ovarian carcinoma: Unraveling biomarkers and therapeutic targets Can't step by? The posters are also available on our website: https://lnkd.in/dVxtS-fm https://lnkd.in/dqcFBHSM
-
🌟 Protai at #ESMO24! 🌟 We are thrilled to announce that at the upcoming ESMO Congress, Protai will be presenting multiple groundbreaking results from our AIMS discovery platform. Here's what to look forward to: 1️⃣ A large scale proteogenomics atlas for precision oncology research. Sunday 15th September, Poster area of Hall 6 2️⃣ Integrative Proteomic Profiling in High-Grade Serous Ovarian Carcinoma: Unraveling Biomarkers and Therapeutic Targets. Sunday 15th September, Poster area of Hall 6 Don’t miss out on these exciting developments! For full details and to schedule a meeting with our team, please contact us at: [email protected]. Eran Seger | Kirill Pevzner | Gali Arad | Nitzan Simchi | Anjana Shenoy #ESMO2024 #AI #Proteomics #PrecisionOncology #Innovation
-
Protai is honored to be featured in TheMarker’s esteemed list of the 20 most promising Israeli startups for 2024. Another testament to our team’s dedication and hard work. https://lnkd.in/d4zYMyew Ruti Levy #themarker #Prize #2024 #Protai #team #Innovation Kirill Pevzner, Eran Seger
-
We are thrilled to welcome Sagie Brodsky, PhD to our Translational Biology team as a Systems Biologist! 🚀 Sagie joins us with valuable experience from the Barkai Lab at the Weizmann Institute of Science and we can’t wait to see the incredible contributions he will make to our mission. Welcome aboard, Sagie! We’re glad to have you on the team! #Protai #Team #Proteomics #AI #SystemsBiology
-
Protai has a new pipeline page 💊 with several programs rapidly progressing towards the clinic. Representing Protai dual R&D effort for biomarker and drug discovery. #Proteomics #AI #PrecisionMedicine https://lnkd.in/dm74BrUJ
-
Our own Nitzan Simchi writes about proteomics dataset harmonization, which powers our clinical proteomics atlas
Data integration is not data harmonization. Discovery proteomics is a pivotal tool in cancer research - analyzing all proteins within cancer cells help to uncover new biomarkers and therapeutic targets. And in proteomics, much like in other data-driven research, integrating multiple datasets is a common practice to increase statistical power and get better biological insights. However, integrating mass spectrometry-based proteomics datasets created from different instrumentation and data acquisition platforms remains substantial. Proteomics faces significant challenges due to nonlinear batch effects - systematic technical variations that arise independently of biological differences when samples are processed using different methods and measured in different batches. These nonlinear effects can become entangled with genuine biological effects, reducing statistical power and limiting reproducibility. This is where cloud computing, AI, and a deep understanding of proteomics data come into play. They enable the harmonization of the ever-growing proteomic atlas of clinical samples, paving the way for better precision medicine. Stay tuned. Protai #AI #Proteomics #Harmonization #Data #PrecisionMedicine
-
Michal Ran Shchory - Welcome to Protai! We are delighted to welcome Michal Ran Shchory to the SW & Algo team! Michal brings with her extensive experience from her technological and management roles in the Intelligence Corps of the IDf. She holds a B.Sc. in Engineering and Physics, as well as a Master's degree in Biomedical Engineering. Notably, Michal's favorite protein is pea protein, a vital component in alternative meats. Welcome to Protai, Michal! #Protai #team #bioinformatics #proteomics #ai
-
Protai פרסם מחדש את זה
Protai is celebrating its 3rd anniversary, marking three successful years of pioneering Proteomics & AI driven drug discovery. 2 cutting-edge drug programs are making rapid progress towards the clinic, with several others on the way. Our brand new lab signifies a pivotal moment as we unite our computational and biological teams under one roof, fostering seamless collaboration and innovation. Great collaborations with top biotech and scientific institutions worldwide are driving impactful outcomes. I'm inspired by the incredible team that has joined our journey - together, we're ready to achieve remarkable things. Kirill Pevzner, Tami Geiger, Sharon Shacham, Giulio Draetta, Gali Arad, Nitzan Simchi, Anjana Shenoy, Lior Handelsman, Ittai Harel #Protai #anniversary #proteomics #ai #drugdiscovery #Teamwork